MANTA闭合装置在经皮血管内主动脉瘤修复术中的临床结局
本研究回顾性分析2018年10月至2022年12月连续152例择期经皮血管内主动脉瘤修复术患者共291次股总动脉MANTA闭合装置闭合,技术成功率96.6%,主要血管并发症4.5%,无死亡相关事件,作者认为MANTA装置安全可行且技术成功率高。
要点
- 152例经皮主动脉瘤修复患者共291次股总动脉MANTA闭合,技术成功率96.6%。
- 主要血管并发症发生率4.5%,无死亡相关事件。
- 作者认为MANTA装置在此类患者中安全可行且技术成功率高。
核心结论
- 作者认为MANTA装置在经皮血管内主动脉瘤修复术患者中安全可行且技术成功率高。
研究设计与样本
- 单中心回顾性队列研究,回顾2018年10月至2022年12月连续152例择期经皮血管内主动脉瘤修复术患者共291次股总动脉MANTA闭合装置闭合。
- 根据鞘管尺寸选用14Fr或18Fr MANTA闭合装置;术前CT测量股总动脉直径并按外周动脉钙化评分系统(PACSS)评估钙化程度。
- 主要结局为手术技术成功,定义为MANTA闭合装置置入后实现血管闭合且股总动脉通畅、无需立即开放或血管内手术;次要结局为30天随访需再干预的入路部位并发症和全因死亡。
主要发现
- 患者平均年龄74.1±6.4岁,平均体重指数27.7±4.4 kg/m2,股总动脉平均直径10.5±1.9 mm。
- 52.6%的病例术前CT未见钙化;18Fr和14Fr MANTA装置分别使用169次和122次。
- 技术成功率为96.6%;主要血管并发症发生率为4.5%,无死亡相关事件。
临床怎么用
- 原文未据此给出推荐;作者结论认为MANTA装置在经皮血管内主动脉瘤修复术患者中安全可行且技术成功率高。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The MANTA device is a plug-based vascular closure device (VCD) designed for large bore femoral arterial access site closure. It showed promising results in transcatheter aortic valve replacement cases. In this study, we report our results and evaluate the MANTA VCD in percutaneous endovascular aortic aneurysm repair (pEVAR). METHODS: All data of consecutive patients who underwent an elective pEVAR between October 2018 and December 2022 were retrospectively reviewed. In all patients at least one common femoral artery was intended to close with the MANTA VCD. Depending on the sheath size, the 14Fr or 18Fr MANTA VCD was used. On the preoperative computed tomography scan, the diameter of the common femoral artery (CFA) was measured and the amount of calcification based on the Peripheral Arterial Calcium Scoring System (PACSS) was scored. Primary outcome was procedural technical success. Procedural technical success was defined as placement of the MANTA closure device resulting in vascular closure with patent CFA, without requiring immediate open or endovascular surgery. The secondary outcomes were access site complications requiring reintervention and all-cause mortality at 30-day follow-up. RESULTS: In total, 152 consecutive patients underwent pEVAR with 291 common femoral artery closure procedures with the Manta VCD. Mean age was 74.1 ± 6.4 years, with a mean body mass index of 27.7 ± 4.4 kg/m2. The mean diameter of the CFA was 10.5 ± 1.9 mm. In 52.6% of the cases, there were no calcification on the preoperative computed tomography scan. The 18Fr and 14Fr Manta VCD were used 169 and 122 times, respectively. The technical success rate was 96.6%. Major vascular complications were reported in 4.5% of the cases, without any death-related events. CONCLUSIONS: This single-center retrospective cohort study analyzed the procedural technical success, major vascular complications and all-cause mortality at 30-day follow-up of the MANTA vascular closure device in 152 pEVAR patients with 291 common femoral artery closure procedures. The technical success rate was 96,6%. Major vascular complications were reported in 4.5% of the cases, without any death related events. We concluded that the MANTA device is a safe and feasible option with a high rate of technical success in patients undergoing pEVAR.
引用
- Peeters M, Oosterveld R, Decraemer G, et al. Clinical outcomes of MANTA closure device in percutaneous endovascular aortic aneurysm repair. J Vasc Surg. 2023. PMID: 37923021. doi:10.1016/j.jvs.2023.10.054
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。